查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600546

血液培養測試市場：按產品、技術、應用和最終用戶分類 - 全球預測 2025-2030

Blood Culture Test Market by Product (Consumable, Instrument, Software and Services), Technology (Culture-Based Technology, Molecular Technology, Proteomics Technology), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

血液培養檢測市場2023年估值為42.3億美元，預計到2024年將達到44.9億美元，複合年成長率為6.18%，預計到2030年將達到64.4億美元。

血液培養檢查是一種重要的診斷工具，用於檢測血液中是否存在細菌和真菌，這可能導致敗血症等嚴重感染疾病。這些測試的需求源於它們在指導有效治療計劃方面的作用，因為及時識別病原體可以顯著改善患者的治療結果。這些測試廣泛應用於各種醫療機構，包括醫院、診所和實驗室。最終用途範圍涵蓋重症加護病房(ICU)、急診室和門診病人設施等各個領域，凸顯了其在醫療保健系統中的廣泛性。

主要市場統計
基準年[2023] 42.3億美元
預測年份 [2024] 44.9億美元
預測年份 [2030] 64.4億美元
複合年成長率（%） 6.18%

根據市場洞察，敗血症和血流感染疾病發病率的增加以及對快速診斷技術的需求不斷成長是市場成長的關鍵驅動力。自動化和靈敏的血液培養系統的開發等技術進步也刺激了市場擴張。此外，人們對早期疾病診斷和抗菌藥物管理計劃重要性的認知不斷提高也有助於擴大市場機會。

然而，先進測試技術的高成本和嚴格的監管要求等挑戰可能會阻礙市場成長。此外，需要技術人員來執行這些測試，這可能會造成額外的障礙，特別是在醫療保健資源有限的地區。

創新可以集中於透過分子診斷和就地檢驗解決方案來提高血液培養檢測的速度和準確性。開發具有成本效益的替代方案並整合人工智慧主導的分析以獲得預測性見解也可以提供重要的業務成長機會。市場動態顯示逐漸轉向自動化和個人化醫療，重點是縮短獲得結果的時間並增加使用者的可及性。尋求新商機的公司可能會發現投資夥伴關係以促進技術進步或透過量身定做的解決方案進入新興市場非常有用。總體而言，市場將經歷相當大的演變，大力推動測試方法的創新，以解決現有的限制並滿足不斷成長的臨床需求。

市場動態：快速發展的血液培養測試市場的關鍵市場洞察

供需的動態交互作用正在改變血液培養檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於血液感染疾病和感染疾病率不斷增加，需要照護現場和快速診斷檢測
    • 增加公共和私人醫療保健支出以改善診斷
    • 政府支持和核准、臨床和實驗室報銷政策
  • 市場限制因素
    • 與受污染的血液培養相關的潛在風險
  • 市場機會
    • 活性化在診斷測試和方法方面的研發 (R&D) 活動
    • 更多採用自動化血液培養測試
  • 市場挑戰
    • 政府對血液培養開發和生產有嚴格的規範

波特五力：駕馭血液培養檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對血液培養檢測市場的影響

外部宏觀環境因素對血液培養檢測市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血液培養檢測市場的競爭狀況

對血液培養測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血液培養檢測市場供應商績效評估

FPNV定位矩陣是評估血液培養檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類了供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著血流感染疾病和感染疾病的增加，需要就地檢驗和快速診斷測試
      • 增加致力於改善診斷的公共和私人醫療保健支出
      • 政府支持和核准、臨床和實驗室報銷政策
    • 抑制因素
      • 與受污染的血液培養相關的潛在風險
    • 機會
      • 推動診斷測試和方法的新研發 (R&D) 活動
      • 更多採用自動化血液培養測試
    • 任務
      • 嚴格的政府血液培養開發和生產標準
  • 市場區隔分析
    • 產品：軟體不斷進步，增強了血液培養資料分析和報告的自動化。
    • 技術：分子技術對病原體的快速和特異性檢測的重要性日益增加
    • 應用：血流感染疾病盛行率的增加正在推動血液培養檢測的使用
    • 最終用戶：學術研究機構擴大使用血液培養檢測來提高病原體檢測的特異性和靈敏度。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章血液培養檢測市場：依產品

  • 消耗品
  • 裝置
  • 軟體和服務

第7章血液培養檢測市場：依技術分類

  • 基於文化的技術
  • 分子技術
  • 蛋白質體學技術

第8章血液培養檢測市場：依應用分類

  • 菌血症
  • 真菌血症
  • 結核分枝桿菌檢測

第9章血液培養檢測市場：依最終用戶分類

  • 學術研究室
  • 醫院實驗室
  • 參考實驗室

第10章美洲血液培養檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區血培養檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲血液培養檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Universal DX 宣布與 Quest Diagnostics 建立戰略合作夥伴關係，為美國患者和醫療保健提供者提供先進的結直腸癌篩檢血液檢測
    • BD 和 Magnolia Medical Technologies 宣佈建立商業合作夥伴關係，以減少血液培養污染並提高測試準確性
    • Accelerate Diagnostics 發布用於血液培養測試的 Arc 系統

公司名單

  • OpGen, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Bruker Corporation
  • Devyser AB
  • Juno Diagnostics, Inc.
  • Thermo Fisher Scientific, Inc.
  • Biomerieux SA
  • Biobase Biodusty（Shandong）, Co., Ltd.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • ZeptoMetrix Corporation
  • Terumo Corporation
  • Novartis AG
  • Neogen Corporation
  • Eli Lilly and Company
  • BINDER GmbH
  • HiMedia Laboratories Pvt. Ltd.
  • Scenker Biological Technology Co., Ltd.
  • T2 Biosystems, Inc.
  • Anaerobe Systems, Inc.
Product Code: MRR-035DA3C63737

The Blood Culture Test Market was valued at USD 4.23 billion in 2023, expected to reach USD 4.49 billion in 2024, and is projected to grow at a CAGR of 6.18%, to USD 6.44 billion by 2030.

Blood culture tests are a critical diagnostic tool used to detect the presence of bacteria or fungi in the blood, which can lead to severe infections such as sepsis. The necessity of these tests stems from their role in guiding effective treatment plans, as timely identification of pathogens can drastically improve patient outcomes. These tests have widespread applications across various healthcare settings, including hospitals, clinics, and laboratories. The end-use scope extends to different departments such as intensive care units (ICUs), emergency rooms, and outpatient facilities, emphasizing their breadth in healthcare systems.

KEY MARKET STATISTICS
Base Year [2023] USD 4.23 billion
Estimated Year [2024] USD 4.49 billion
Forecast Year [2030] USD 6.44 billion
CAGR (%) 6.18%

Market insights reveal that the growing incidence of sepsis and bloodstream infections, coupled with the rising demand for rapid diagnostic techniques, are significant driving factors for market growth. Advances in technology, such as the development of automated and more sensitive blood culture systems, are also stimulating market expansion. Additionally, increasing awareness about early disease diagnosis and the importance of antimicrobial stewardship programs contribute to market opportunities.

However, challenges such as high costs of advanced testing technologies and stringent regulatory requirements may impede market growth. Moreover, the need for skilled personnel to conduct these tests can pose additional barriers, particularly in regions with limited healthcare resources.

Innovation could focus on enhancing the speed and accuracy of blood culture tests through molecular diagnostics and point-of-care testing solutions. Developing cost-effective alternatives and integrating AI-driven analytics for predictive insights could also offer substantial business growth opportunities. Market dynamics suggest a gradual shift towards automation and personalized medicine, with an emphasis on reducing time-to-result and improving user accessibility. For businesses looking to explore new opportunities, investing in partnerships for technological advancement or entering emerging markets with tailored solutions could be beneficial. Overall, the market is poised for considerable evolution, with a strong push towards innovation in testing methods to address existing limitations and meet growing clinical demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Culture Test Market

The Blood Culture Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need for Point-of-Care and Rapid Diagnostic Tests Owing to the Growing Prevalence of Bloodstream Infections and Infectious Diseases
    • Rising Public and Private Healthcare Expenditure Specifically for the Improved Diagnosis
    • Government Support and Approval Along with Clinical and Lab Reimbursement Policies
  • Market Restraints
    • Potential Risk Associated with Contaminated Blood Culture
  • Market Opportunities
    • Emerging Research and Development (R&D) Activities in the Advancement of Diagnostic Tests and Methods
    • Rising Adoption of Automated Blood Culture Tests
  • Market Challenges
    • Strict Government Norms in the Development and Production of Blood Cultures

Porter's Five Forces: A Strategic Tool for Navigating the Blood Culture Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Culture Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Culture Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Culture Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Culture Test Market

A detailed market share analysis in the Blood Culture Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Culture Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Culture Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Blood Culture Test Market, highlighting leading vendors and their innovative profiles. These include OpGen, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Bruker Corporation, Devyser AB, Juno Diagnostics, Inc., Thermo Fisher Scientific, Inc., Biomerieux SA, Biobase Biodusty(Shandong), Co., Ltd., Autobio Diagnostics Co., Ltd., Becton, Dickinson and Company, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, F. Hoffmann-La Roche Ltd., ZeptoMetrix Corporation, Terumo Corporation, Novartis AG, Neogen Corporation, Eli Lilly and Company, BINDER GmbH, HiMedia Laboratories Pvt. Ltd., Scenker Biological Technology Co., Ltd., T2 Biosystems, Inc., and Anaerobe Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Culture Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumable, Instrument, and Software and Services.
  • Based on Technology, market is studied across Culture-Based Technology, Molecular Technology, and Proteomics Technology.
  • Based on Application, market is studied across Bacteremia, Fungemia, and Mycobacterial Detection.
  • Based on End User, market is studied across Academic Research Laboratories, Hospital Laboratories, and Reference Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for Point-of-Care and Rapid Diagnostic Tests Owing to the Growing Prevalence of Bloodstream Infections and Infectious Diseases
      • 5.1.1.2. Rising Public and Private Healthcare Expenditure Specifically for the Improved Diagnosis
      • 5.1.1.3. Government Support and Approval Along with Clinical and Lab Reimbursement Policies
    • 5.1.2. Restraints
      • 5.1.2.1. Potential Risk Associated with Contaminated Blood Culture
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Research and Development (R&D) Activities in the Advancement of Diagnostic Tests and Methods
      • 5.1.3.2. Rising Adoption of Automated Blood Culture Tests
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Government Norms in the Development and Production of Blood Cultures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Ongoing advancement in the softwares to enhance automation in blood culture data analysis and reporting.
    • 5.2.2. Technology: Growing significance of molecular technology due to its rapid and specific detection of pathogens
    • 5.2.3. Application: Increasing prevalence of bloodstream infections driving the utilization of blood culture test
    • 5.2.4. End User: Rising utilization of blood culture test by academic research laboratories for to enhance the specificity and sensitivity of pathogen detection
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Blood Culture Test Market, by Product

  • 6.1. Introduction
  • 6.2. Consumable
  • 6.3. Instrument
  • 6.4. Software and Services

7. Blood Culture Test Market, by Technology

  • 7.1. Introduction
  • 7.2. Culture-Based Technology
  • 7.3. Molecular Technology
  • 7.4. Proteomics Technology

8. Blood Culture Test Market, by Application

  • 8.1. Introduction
  • 8.2. Bacteremia
  • 8.3. Fungemia
  • 8.4. Mycobacterial Detection

9. Blood Culture Test Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Laboratories
  • 9.3. Hospital Laboratories
  • 9.4. Reference Laboratories

10. Americas Blood Culture Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Culture Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Culture Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
    • 13.3.2. BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy
    • 13.3.3. Accelerate Diagnostics Launches Arc System for Use in Blood Culture Test

Companies Mentioned

  • 1. OpGen, Inc.
  • 2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 3. Bruker Corporation
  • 4. Devyser AB
  • 5. Juno Diagnostics, Inc.
  • 6. Thermo Fisher Scientific, Inc.
  • 7. Biomerieux SA
  • 8. Biobase Biodusty(Shandong), Co., Ltd.
  • 9. Autobio Diagnostics Co., Ltd.
  • 10. Becton, Dickinson and Company
  • 11. Abbott Laboratories
  • 12. Siemens Healthineers AG
  • 13. Danaher Corporation
  • 14. F. Hoffmann-La Roche Ltd.
  • 15. ZeptoMetrix Corporation
  • 16. Terumo Corporation
  • 17. Novartis AG
  • 18. Neogen Corporation
  • 19. Eli Lilly and Company
  • 20. BINDER GmbH
  • 21. HiMedia Laboratories Pvt. Ltd.
  • 22. Scenker Biological Technology Co., Ltd.
  • 23. T2 Biosystems, Inc.
  • 24. Anaerobe Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. BLOOD CULTURE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD CULTURE TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD CULTURE TEST MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CULTURE-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PROTEOMICS TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACTEREMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY FUNGEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MYCOBACTERIAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2023